Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Jacqueline A. Pongracic(Lurie Children's Hospital), Philippe Bégin(Université de Montréal), Terri F. Brown‐Whitehorn(Children's Hospital of Philadelphia), Sayantani Sindher(Johns Hopkins University), Amy M. Scurlock(Johns Hopkins University), Allan Stillerman(Asthma and Allergy Specialists), Hugh A. Sampson(ENT and Allergy), Roxanne C. Oriel(Icahn School of Medicine at Mount Sinai), David M. Fleischer(Children's Hospital Colorado), Andrew J. MacGinnitie(Boston Children's Hospital), Dareen Siri(Mid Illinois Hematology and Oncology Associates), J. Andrew Bird, Amarjit Cheema(Research Canada), Hemalini Mehta(Asthma and Allergy Specialists), Dianne E. Campbell(Children's Hospital at Westmead), Daniel Petroni(Allergy, Asthma and Clinical Research Center), Timothée Bois(DBV Technologies (France)), Hey Chong(Children's Hospital of Pittsburgh), Bruce J. Lanser(Johns Hopkins University), Erika Gonzalez-Reyes(Allergy and Asthma Medical Group and Research Center), Stanley M. Fìneman(Emory University), Lynda C. Schneider(Children's Hospital), Paul Dowling(Children's Mercy Hospital), Edwin Kim(Johns Hopkins University), Todd D. Green(DBV Technologies (France)), Wayne G. Shreffler(ENT and Allergy), Sara Anvari(Baylor College of Medicine), Robert A. Wood(Johns Hopkins University), William E. Berger(California Allergy and Asthma Medical Group), Lawrence Sher(Peninsula Research), Gordon L. Sussman, William H. Yang(Ottawa Allergy Research Corporation), Ned T. Rupp, Edmond S. Chan(University of British Columbia), Rémi Gagnon, R. Sharon Chinthrajah(Johns Hopkins University)
The Journal of Allergy and Clinical Immunology In Practice
November 27, 2021
Cited by 61


Related Papers